Seminar: Proteomic mapping reveals molecular determinants of FGF receptor signalling and trafficking
Dr. Jørgen Wesche, Group leader Molecular Biology of Sarcomas at Institute for Cancer Research, Oslo University Hospital
Published Sep. 22, 2017 11:37 AM
- Last modified Aug. 11, 2022 12:46 AM